Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study.
Munárriz J, Reynés G, Sánchez-Lorenzo L, Esteban E, Basterretxea L, de Avila-Lizárraga L, Climent MA, Juan-Fita MJ, Escoín C, Puente J, Cassinello J, Vázquez S, Chirivella I.
Munárriz J, et al. Among authors: escoin c.
Cancer Chemother Pharmacol. 2019 Oct;84(4):781-789. doi: 10.1007/s00280-019-03913-3. Epub 2019 Jul 31.
Cancer Chemother Pharmacol. 2019.
PMID: 31367791